Brokers Offer Predictions for VNDA FY2026 Earnings
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) – Equities research analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for Vanda Pharmaceuticals in a note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst O. Brayer anticipates that the biopharmaceutical company will post earnings per share of $0.07 for the year. […]
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) – Equities research analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for Vanda Pharmaceuticals in a note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst O. Brayer anticipates that the biopharmaceutical company will post earnings per share of $0.07 for the year. […]
